The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Open accessAbstract
This study aimed to determine if there is an association between dysbiosis and nonalcoholic fatty liver disease (NAFLD) independent of obesity and insulin resistance (IR). This is a prospective cross-sectional study assessing the intestinal microbiome (IM) of 39 adults with biopsy-proven NAFLD (15 simple steatosis [SS]; 24 nonalcoholic steatohepatitis [NASH]) and 28 healthy controls (HC). IM composition (llumina MiSeq Platform) in NAFLD patients compared to HC were identified by two statistical methods (Metastats, Wilcoxon). Selected taxa was validated using quantitative PCR (qPCR). Metabolites in feces and serum were also analyzed. In NAFLD, 8 operational taxonomic units, 6 genera, 6 families and 2 phyla (Bacteroidetes, Firmicutes) were less abundant and; 1 genus ( Lactobacillus ) and 1 family (Lactobacillaceae) were more abundant compared to HC. Lower abundance in both NASH and SS patients compared to HC were confirmed by qPCR for Ruminococcus, Faecalibacterium prausnitzii and Coprococcus . No difference was found between NASH and SS. This lower abundance in NAFLD (NASH+SS) was independent of BMI and IR. NAFLD patients had higher concentrations of fecal propionate and isobutyric acid and serum 2-hydroxybutyrate and L-lactic acid. These findings suggest a potential role for a specific IM community and functional profile in the pathogenesis of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, diseases linked to dyslipidemia, such as non-alcoholic liver disease and atherosclerosis, are associated with changes in gut microbiota profile.”
From Dietary lipids, gut microbiota and lipid metabolism (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 21,098
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Research works printed but not linked: 1
- Doelle, H. W. Bacterial Metabolism. Second edn, 416–419 (Academic Press, Inc., 1975).
Cited by
Sorted by citations
Items 101–200 of 283
Shi, J., Yang, Y., Xu, W., Cai, H., Wu, J., Long, J., Cai, Q., Zheng, W., Flynn, C. R., Shu, X., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9102118 · Cited by 32
Chen, X., Liu, M., Tang, J., Wang, N., Feng, Y., & Ma, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911710 · Cited by 33
Han, X., Wang, Y., Zhang, P., Zhu, M., Li, L., Mao, X., Sha, X., & Li, L. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1954667 · Cited by 32
C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population
Atsawarungruangkit, A., Chenbhanich, J., & Dickstein, G. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i32.3663 · Cited by 31
Bahitham, W., Banoun, Y., Aljahdali, M., Almuaiqly, G., Bahshwan, S. M., Aljahdali, L., Sanai, F. M., Rosado, A. S., & Sergi, C. M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1637071 · Cited by 36
Hepatic glycogen storage diseases are associated to microbial dysbiosis
Colonetti, K., dos Santos, B. B., Nalin, T., de Souza, C. F. M., Triplett, E. W., Dobbler, P. T., Schwartz, I. V. D., & Roesch, L. F. W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214582 · Cited by 30
The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
Houttu, V., Boulund, U., Grefhorst, A., Soeters, M. R., Pinto‐Sietsma, S., Nieuwdorp, M., & Holleboom, A. G. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820941745 · Cited by 32
Does Gut-Microbiome Interaction Protect against Obesity and Obesity-Associated Metabolic Disorders?
Zawada, A. E., Rychter, A. M., Ratajczak, A. E., Lisiecka-Masian, A., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2020) · Microorganisms · doi:10.3390/microorganisms9010018 · Cited by 29
Lang, S., Martin, A., Zhang, X., Farowski, F., Wisplinghoff, H., Vehreschild, M. J. G. T., Krawczyk, M. J., Nowag, A., Kretzschmar, A., Scholz, C. J., et al. (2021) · Liver International · doi:10.1111/liv.14899 · Cited by 29
Pedersen, K. B., Pulliam, C. F., Patel, A., Piero, F. D., Watanabe, T. T. N., Wankhade, U. D., Shankar, K., Hicks, C., & Ronis, M. J. J. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy141 · Cited by 28
Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
Albhaisi, S. A. M., & Sanyal, A. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665987 · Cited by 28
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
Baumann, A., Nier, A., Hernández-Arriaga, A. M., Brandt, A., Pisarello, M. J. L., Jin, C. J., Pilar, E., Camarinha‐Silva, A., Schattenberg, J. M., & Bergheim, I. (2021) · Scientific Reports · doi:10.1038/s41598-021-97346-9 · Cited by 28
Yao, N., Yang, Y., Li, X., Wang, Y., Guo, R., Wang, X., Li, J., Xie, Z., Li, B., & Cui, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.906511 · Cited by 29
Schwenger, K. J. P., Chen, L., Chelliah, A., Silva, H. D., Teterina, A. A., Comelli, E. M., Taïbi, A., Arendt, B. M., Fischer, S. E., & Allard, J. P. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3800 · Cited by 28
Self-citationKenyon, J., Coe, S., & Izadi, H. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2019.100061 · Cited by 28
Microbiota and viral hepatitis: State of the art of a complex matter
Milošević, I., Russo, E., Vujović, A., Barac, A. M., Stevanović, O., Gitto, S., & Amedei, A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i33.5488 · Cited by 31
Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review
Chen, Y., Wu, W., & Wu, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175999 · Cited by 29
Zhang, J., Wang, W., Cui, X., Zhu, P.-L., Li, S., Yuan, S., Peng, D., & Peng, C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117656 · Cited by 26
Feng, R., Yang, W., Feng, W., Huang, X., Cen, M., Peng, G., Wu, W., Wang, Z., Jing, Y., Long, T., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2390164 · Cited by 25
Chiu, Y., Chou, W.-L., Ko, M.-C., Liao, J.-C., & Huang, T. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109920 · Cited by 26
Sookoian, S. C., & Pirola, C. J. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-20-270 · Cited by 24
Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
Satapathy, S. K., Banerjee, P., Pierre, J. F., Higgins, D., Dutta, S., Heda, R. P., Khan, S. D., Mupparaju, V. K., Mas, V. R., Nair, S. P., et al. (2020) · Transplantation Direct · doi:10.1097/txd.0000000000001033 · Cited by 25
Mazzini, F. N., Cook, F., Gounarides, J., Marciano, S., Haddad, L., Tamaroff, A. J., Casciato, P. C., Narvaez, A., Mascardi, M. F., Anders, M., et al. (2021) · Metabolomics · doi:10.1007/s11306-021-01810-6 · Cited by 26
Noorian, S., Jeon, Y., Nguyen, M. T. T., Sauk, J. S., & Limketkai, B. N. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab199 · Cited by 25
Cai, W., Qiu, T. H., Hu, W., & Fang, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299946 · Cited by 25
Singh, P., Meenatchi, R., Ahmed, Z., Thacharodi, A., Rohinth, M., Kumar, R. R., K, H. V. M., & Hassan, S. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100096 · Cited by 30
Gut Microbiota Interactions With Obesity
Falalyeyeva, T. M., Chornenka, N., Cherkasova, L., Tsyryuk, O., Molchek, N., Kovalchuk, O. I., Kyriachenko, Y., Остапченко, Л. І., & Kobyliak, N. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00030-9 · Cited by 24
Korobeinikova, A. V., Zlobovskaya, O. A., Sheptulina, A. F., Ashniev, G. A., Bobrova, M. M., Yafarova, A. A., Akasheva, D. U., Kabieva, S. S., Bakoev, S., Zagaynova, A. V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015272 · Cited by 26
Gil‐Gómez, A., Brescia, P., Rescigno, M., & Romero‐Gómez, M. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1723752 · Cited by 24
Hintikka, J. E., Lensu, S., Mäkinen, E., Karvinen, S. M., Honkanen, M., Lindén, J., Garrels, T., Pekkala, S., & Lahti, L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084049 · Cited by 21
Bahitham, W., Alghamdi, S., Omer, I., Alsudais, A. S., Hakeem, I., Alghamdi, A., Abualnaja, R., Sanai, F. M., Rosado, A. S., & Sergi, C. M. (2024) · Biomedicines · doi:10.3390/biomedicines12030550 · Cited by 22
Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
Moszak, M., Szulińska, M., Walczak-Galezewska, M. K., & Bogdański, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041616 · Cited by 21
Gupta, M., Krishan, P., Kaur, A., Arora, S., Trehanpati, N., Singh, T. G., & Bedi, O. (2021) · Inflammation Research · doi:10.1007/s00011-021-01480-z · Cited by 21
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Alisi, A., McCaughan, G. W., & Grønbæk, H. (2024) · Hepatology International · doi:10.1007/s12072-024-10674-6 · Cited by 21
Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
Dong, T. S., & Jacobs, J. P. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219836739 · Cited by 22
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease
Hartmann, P., & Schnabl, B. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1719174 · Cited by 22
Gut Feelings: How Microbes, Diet, and Host Immunity Shape Disease
Theis, B. F., Park, J. S., Kim, J. S., Zeydabadinejad, S., Vijay–Kumar, M., Yeoh, B. S., & Saha, P. (2025) · Biomedicines · doi:10.3390/biomedicines13061357 · Cited by 24
Sabirin, F., Lim, S. M., Neoh, C. F., & Ramasamy, K. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.844374 · Cited by 21
Short chain fatty acids for the risk of diabetic nephropathy in type 2 diabetes patients
Li, Y., Qin, G.-Q., Wang, W., Liu, X., Gao, X., Liu, J., Zheng, T., Zhang, W., Cheng, L., Yang, K., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01870-7 · Cited by 20
Environmental pollutant-mediated disruption of gut microbial metabolism of the prebiotic inulin
Hoffman, J. B., Flythe, M. D. D., & Hennig, B. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.11.008 · Cited by 20
Daniel, N., Perazza, L. R., Varin, T. V., Trottier, J., Marcotte, B., St‐Pierre, P., Barbier, O., Chassaing, B., & Marette, A. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00028.2021 · Cited by 19
Dual Role of Pregnane X Receptor in Nonalcoholic Fatty Liver Disease
Xu, Y., An, Z., Wang, S., Ni, Y., Zhou, M., Feng, Q., Gou, X., Xu, M., & Qi, Y. (2023) · Current Molecular Pharmacology · doi:10.2174/0118761429259143230927110556 · Cited by 19
Chen, X., Zou, G., Yang, Z., Qi, X., Song, F., Peng, L., Wang, D., Zhou, J. H., Ma, J., He, H., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103546 · Cited by 19
Kirby, T. O., Ochoa‐Repáraz, J., Roullet, J., & Gibson, K. M. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.12.289 · Cited by 20
Liu, K., Chen, S., Huang, J., Ren, F., Yang, T., Long, D., Li, H., & Huang, X. (2021) · Microorganisms · doi:10.3390/microorganisms9051030 · Cited by 19
Probiotics and obesity associated disease: an extended view beyond traditional strains
Falalyeyeva, T. M., MAMULA, Y., Scarpellini, E., Leshchenko, I. V., HUMENIUK, A., Pankiv, І. V., & Kobyliak, N. M. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02909-0 · Cited by 19
Forlano, R., Sivakumar, M., Mullish, B. H., & Manousou, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158307 · Cited by 20
Key Stratification of Microbiota Taxa and Metabolites in the Host Metabolic Health–Disease Balance
Torres-Sánchez, A., Ruiz-Rodriguez, A., Ortíz, P., & Aguilera, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054519 · Cited by 19
Pekkala, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054855 · Cited by 22
Guo, G.-J., Yao, F., Lu, W.-P., & Xu, H. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i7.867 · Cited by 19
García, S. G., Rondinella, D., Ponziani, F. R., Miele, L., Gasbarrini, A., Cammarota, G., Lanas, Á., & Gomollón, F. (2024) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2024.101924 · Cited by 20
Gut microbiota and non-alcoholic fatty liver disease
Abenavoli, L., Procopio, A. C., Scarpellini, E., POLIMENI, N., AQUILA, I., LARUSSA, T., BOCCUTO, L., & Luzza, F. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02896-5 · Cited by 19
Han, J. H., Rey, F. E., & Denu, J. M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110521 · Cited by 21
Circulating metabolite signatures indicate differential gut-liver crosstalk in lean and obese MASLD
Haag, M., Winter, S., Kemas, A. M., Tevini, J., Feldman, A., Eder, S. K., Felder, T. K., Datz, C., Paulweber, B., Liebisch, G., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.180943 · Cited by 21
Ahmed, F., Arshad, M. T., Maqsood, S., Ikram, A., & Gnedeka, K. T. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70689 · Cited by 22
Chen, Y., Jiang, S., Wang, H., Si, M., Wu, H., Liang, X., Yao, S., Zhang, Y., Wen, X., & Yang, J. (2025) · Advanced Science · doi:10.1002/advs.202502624 · Cited by 17
Bi, C., Sun, J.-T., Du, J., Chu, L.-Y., Li, Y., Jia, X.-Y., Liu, Y., Zhang, W., Li, Y.-C., & Liu, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1005318 · Cited by 17
Risk of Kidney Dysfunction IN Nafld
Mantovani, A., Zusi, C., Dalbeni, A., Grani, G., & Buzzetti, E. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191026113119 · Cited by 17
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
Pandey, H., Goel, P., Srinivasan, V. M., Tang, D. W. T., Wong, S. H., & Lal, D. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i6.106849 · Cited by 20
Salazar, N., González, S., Gavilan, C. G. D. L. R., & Ríos-Covián, D. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81304-8_4-1 · Cited by 15
Delik, A., Dinçer, S., Ülger, Y., Akkız, H., & Karaoğullarından, Ü. (2022) · Gene · doi:10.1016/j.gene.2022.146587 · Cited by 15
Gut microbial metabolites of amino acids in liver diseases
Hu, M., Xu, Y., Zhou, H., & He, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2586328 · Cited by 17
Signs of aging in midlife: physical function and sex differences in microbiota
Tzemah-Shahar, R., Turjeman, S., Sharon, E., Gamliel, G., Hochner, H., Koren, O., & Agmon, M. (2023) · GeroScience · doi:10.1007/s11357-023-00905-3 · Cited by 16
Sun, C., Lan, F., Zhou, Q., Guo, X., Jin, J., Wen, C., Guo, Y., Hou, Z., Zheng, J., Wu, G., et al. (2024) · GigaScience · doi:10.1093/gigascience/giae023 · Cited by 14
Singh, S., Kriti, M., Catanzaro, R., Marotta, F., Malvi, M., Jain, A. K., Verma, V., Nagpal, R., Tiwari, R. R., & Kumar, M. (2024) · Livers · doi:10.3390/livers4030032 · Cited by 16
Ralli, T., Neupane, Y. R., Saifi, Z., & Kohli, K. (2021) · Current Pharmaceutical Design · doi:10.2174/1389201022666210625141526 · Cited by 14
Geng, W., Zhang, Y., Yang, H. J., Zhang, J., Zhao, J., Wang, J., Jia, L., & Wang, Y. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11820 · Cited by 14
Immunomodulatory role of Faecalibacterium prausnitzii in obesity and metabolic disorders
Yousefi, B., Mohammadlou, M., Bahar, A., Falalyeyeva, T. M., Kobyliak, N. M., & Eslami, M. (2021) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.21.02759-2 · Cited by 13
Reuter, B., & Bajaj, J. S. (2020) · Clinics in Liver Disease · doi:10.1016/j.cld.2020.04.006 · Cited by 13
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?
Singh, S. P., Anirvan, P., Khandelwal, R., & Satapathy, S. K. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00174 · Cited by 12
Won, S., Joung, H., Park, I. G., Han, S. H., Ham, Y. L., Han, J.-S., Kwon, Y., Kim, D. J., & Suk, K. T. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07478-z · Cited by 12
Milton‐Laskibar, I., Marcos-Zambrano, L. J., Gómez‐Zorita, S., Pau, E. C. D. S., Fernández‐Quintela, A., Martínez, J. A., & Portillo, M. P. (2022) · Gut Microbiome · doi:10.1017/gmb.2022.2 · Cited by 10
Qiu, B., Shen, Z., Yang, D., Qin, X., Ren, W., & Wang, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1273269 · Cited by 11
Faucher, Q., Jardou, M., Brossier, C., Picard, N., Marquet, P., & Lawson, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.898878 · Cited by 14
Coleman, M. J., Espino, L. M., Lebensohn, H., Zimkute, M. V., Yaghooti, N., Ling, C. L., Gross, J., Listwan, N., Cano, S., Garcia, V., et al. (2022) · Metabolites · doi:10.3390/metabo12050431 · Cited by 12
Tan, Y., Hu, Y., Yang, Y., & Chu, H. (2025) · MedComm · doi:10.1002/mco2.70532 · Cited by 13
Bentanachs, R., Miró, L., Sánchez, R. M., Ramírez-Carrasco, P., Amat, C., Alegret, M., Pérez, A., Roglans, N., & Laguna, J. C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117067 · Cited by 11
Sharma, J., & Dey, P. (2024) · Molecular Omics · doi:10.1039/d4mo00140k · Cited by 10
Hou, Y., Gao, X., Gong, J., Dong, X., Hao, Y., Zhai, Z., Zhang, H., Zhang, M., Liu, R., Wang, R., et al. (2025) · Nutrients · doi:10.3390/nu17050930 · Cited by 12
Münte, E., Viebahn, G., Khurana, A., Fujiki, J., Nakamura, T., Lang, S., Demir, M., Schnabl, B., & Hartmann, P. (2025) · Microorganisms · doi:10.3390/microorganisms13030675 · Cited by 11
Zhang, X., Sun, M., Li, D., Miao, X., Mei, H., Sun, R., Su, Y., Chi, Y., Wang, J., & Niu, H. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/5876706 · Cited by 10
Fat and hepatocellular carcinoma
Balsano, C., Porcu, C., Sideri, S., & Tavolaro, S. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.51 · Cited by 10
Gut microbiota and atrial cardiomyopathy
Sun, T., Song, B., & Li, B. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1541278 · Cited by 10
Sarwono, K. A., Kondo, M., Ban‐Tokuda, T., Jayanegara, A., & Matsui, H. (2019) · Tropical Animal Science Journal · doi:10.5398/tasj.2019.42.2.121 · Cited by 9
Schwenger, K. J. P., Kiu, A., Alali, M., Alhanaee, A., Fischer, S. E., & Allard, J. P. (2021) · Nutrition · doi:10.1016/j.nut.2021.111491 · Cited by 10
Self-citationINASL–SAASL Consensus Statements on NAFLD Name Change to MAFLD
Singh, S. P., Duseja, A. K., Mahtab, M. A., Anirvan, P., Acharya, S. K., Akbar, S. M. F., Butt, A. S., Dassanayake, A. S., De, A., Dhakal, G. P., et al. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.12.011 · Cited by 9
Szydlowska, M., Lasky, G., Oldham, S. N., Rivera, C., Ford, M., Sellman, B. R., Rhodes, C. J., & Cohen, T. S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166697 · Cited by 9
The interplay between host cellular and gut microbial metabolism in NAFLD development and prevention
Yu, S., & Xu, L. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14992 · Cited by 9
Won, S., Seo, M. J., Kwon, M. J., Park, K. W., & Yoon, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.746601 · Cited by 9
Editorial: The Microbiome in Hepatobiliary and Intestinal Disease
Hartmann, P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.893074 · Cited by 9
Peloso, A., Tihy, M., Moeckli, B., Rubbia‐Brandt, L., & Toso, C. (2022) · Nutrients · doi:10.3390/nu14245340 · Cited by 8
Nonalcoholic Fatty Liver Disease: Changes in Gut Microbiota and Blood Lipids
Yang, K., Zeng, J., Wu, H., Liu, H., Ding, Z., Liang, W., Wu, L., Lin, Z., Huang, W., Xu, J., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00199 · Cited by 8
Dong, H., Yang, X., Zhou, Y., Yang, M. Q., Zhang, H., Liu, X., & Zhu, W. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.14371 · Cited by 8
Dong, T. S., Luu, K., Lagishetty, V., Sedighian, F., Woo, S., Dreskin, B. W., Katzka, W. R., Chang, C., Zhou, Y., Arias-Jayo, N., et al. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.55 · Cited by 8
Ahuja, A., Dhanalekshmi, U. M., Saraswathy, M. P., Nandakumar, S., Francis, A. P., & Gurpreet, K. N. (2022) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/2949681015666220615120300 · Cited by 8
Csader, S., Chen, X., Leung, H., Männistö, V., Pentikäinen, H., Tauriainen, M., Savonen, K. P., El-Nezami, H. S., Schwab, U., & Panagiotou, G. (2023) · mSystems · doi:10.1128/msystems.00224-23 · Cited by 9
Cardiovascular Manifestations of Patients with Non-Alcoholic Fatty Liver Disease
Pădureanu, V., Forțofoiu, M.-C., Pîrșcoveanu, M., Pădureanu, R., Rădulescu, D., Donoiu, I., & Pîrșcoveanu, D. F. V. (2025) · Metabolites · doi:10.3390/metabo15030149 · Cited by 8
Yogurt and health: a focus on its matrix
Tremblay, A., Drouin‐Chartier, J., Marette, A., & Drapeau, V. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2524472 · Cited by 9
Sun, R., Niu, H., Li, Y., Sun, M., Hua, M., Miao, X., Su, Y., Wang, J., Li, D., & Wang, Y. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae003 · Cited by 7
Host—microbial interactions in metabolic diseases: from diet to immunity
Lee, J.-H., & Park, J. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-2087-y · Cited by 7
Metadata
- Authors
- Da Silva, H. E., Teterina, A., Comelli, E. M., Taibi, A., Arendt, B. M., Fischer, S. E., Lou, W., & Allard, J. P.
- Affiliations
- University Health Network (CA)
- University of Toronto (CA)
- Corresponding author
- Allard, Johane P.
- ORCID
- Venue
- Scientific Reports
- Published
- 2018-01-23
- Volume
- 8
- Issue
- 1
- Pages
- 1466-1466
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5780381
- OpenAlex
- W2803148575
- Cited by
- 283
- References
- 59
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 31 · 2023: 34 · 2022: 35 · 2021: 60 · 2020: 34 · 2019: 27 · 2018: 10
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American College of Gastroenterology
- University of Alberta
- University of Toronto
- Canadian Institutes of Health Research (86922_1, 89705_1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut microbiota, dysbiosis, obesity, insulin resistance, Bacteroidetes, Firmicutes, Faecalibacterium prausnitzii, Ruminococcus, Coprococcus, Lactobacillus, short-chain fatty acids, propionate, isobutyric acid, 2-hydroxybutyrate, L-lactic acid, gut microbiota metabolites
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Cross-Sectional Studies, Feces, Female, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Prospective Studies, Body Mass Index, Young Adult, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
